Chemicals · Founded 1972 · www.tanfac.com · BSE 506854 · NSE TANFAC IND. · ISIN INE639B01023
No Notes Added Yet
Business
Tanfac Industries Ltd. is an India-based chemical manufacturing company. It is a joint venture between Grasim Industries Ltd. (part of the Aditya Birla Group) and Tamil Nadu Industrial Development Corporation (TIDCO). The company manufactures a range of fluorine-based chemicals and sulphuric acid. Its core business involves the production of Anhydrous Hydrofluoric Acid (AHF), Aluminium Fluoride (ALF), Sulphuric Acid, and various Specialty Fluorides. Tanfac makes money by selling these industrial chemicals to various end-user industries such as refrigerants, pharmaceuticals, agrochemicals, aluminum smelting, and general industrial applications.
Revenue Mix
Tanfac Industries primarily derives its revenue from two broad categories:
Fluorine-based chemicals: This segment includes Anhydrous Hydrofluoric Acid (AHF), Aluminium Fluoride (ALF), and various Specialty Fluorides. These products cater to industries like refrigerants, propellants, fluoropolymers, aluminum smelting, pharmaceuticals, and agrochemicals.
Sulphuric Acid: This is a key industrial chemical with wide applications in fertilizers, chemicals, textiles, and other manufacturing processes.
Specific revenue contributions from each product or segment are not publicly detailed with consistent percentages, but fluorine derivatives are generally considered the core and higher-value segment.
Industry
Tanfac operates within the Indian chemicals industry, specifically specializing in fluorochemicals and bulk acids. The fluorochemicals market is characterized by high entry barriers due to complex manufacturing processes, significant capital investment, stringent environmental regulations, and specialized technology requirements. Tanfac is one of the few integrated manufacturers of hydrofluoric acid and its derivatives in India. Its positioning is as a established domestic player with a strong focus on these niche but critical chemicals, facing competition from other domestic players like Gujarat Fluorochemicals and imports. Its association with the Aditya Birla Group provides it with a stable backing and governance framework.
MOAT
Tanfac possesses several potential competitive advantages:
High Entry Barriers: The significant capital expenditure, technical know-how, and environmental clearances required for fluorochemical production limit new entrants, providing a structural advantage.
Integrated Manufacturing: Its integrated facility for hydrofluoric acid and its derivatives can offer cost efficiencies and supply chain stability.
Long-standing Relationships: As an established player, it likely has long-term supply relationships with key industrial customers, leading to stickiness.
Parentage: Being associated with the Aditya Birla Group (via Grasim Industries) provides access to capital, managerial expertise, and a strong brand reputation, which can build trust with customers and suppliers.
Growth Drivers
Key factors that can drive Tanfac's growth over the next 3-5 years include:
Growing demand for refrigerants: Increased disposable incomes and infrastructure development in India drive demand for air conditioning and refrigeration, boosting demand for fluorochemicals.
Expansion in end-user industries: Growth in the pharmaceutical, agrochemical, and specialty chemicals sectors will fuel demand for its specialty fluorides.
Aluminum sector growth: Demand for Aluminium Fluoride is tied to the growth of the primary aluminum industry, which benefits from infrastructure and industrial expansion.
Import substitution: Government initiatives promoting domestic manufacturing and reducing reliance on imports can provide opportunities.
Capacity Expansion: Any future capital expenditure plans to increase production capacity for its key products will directly support volume growth.
Risks
Raw Material Price Volatility: Key raw materials like Fluorspar (for HF) and Sulphur (for Sulphuric Acid) are globally traded commodities, making the company susceptible to price fluctuations that can impact profitability.
Environmental Regulations: The chemical industry is subject to evolving and stringent environmental, health, and safety regulations, which can lead to increased compliance costs or operational restrictions.
Import Competition: Despite high entry barriers, competition from cheaper imports, especially from China, can put pressure on pricing and market share.
Economic Slowdown: A general economic downturn in India or globally could reduce demand from key end-user industries.
Technological Obsolescence: Changes in technology (e.g., development of new, environmentally friendlier refrigerants) could impact demand for existing fluorochemicals.
Management & Ownership
Tanfac Industries Ltd. is jointly promoted by Grasim Industries Ltd. (part of the Aditya Birla Group) and Tamil Nadu Industrial Development Corporation (TIDCO). Grasim Industries holds a significant equity stake, making it a key promoter and influencing strategic direction and governance. This association with the Aditya Birla Group generally implies a professional management team, adherence to strong corporate governance practices, and access to a broad pool of talent and resources. The board typically includes representatives from both promoter entities, ensuring oversight and alignment with the long-term objectives of the joint venture partners.
Outlook
Tanfac Industries benefits from its established position and technical expertise in the specialized fluorochemicals market, coupled with the strong backing of the Aditya Birla Group. The growing demand from key end-user industries like refrigerants, pharmaceuticals, and agrochemicals provides a supportive environment for its core products. However, the company operates in a capital-intensive industry susceptible to raw material price volatility and stringent environmental regulations. While its specialized product portfolio and high entry barriers offer some protection, competition from imports and potential shifts in end-user technologies remain factors to monitor. Future growth will largely depend on its ability to manage input costs, navigate regulatory landscapes, and capitalize on domestic demand expansion.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 88 | 103 | 95 | 112 | 178 | 172 | 176 | 169 | 173 | 193 |
| Other Income | 1 | 2 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 |
| Total Income | 89 | 105 | 97 | 112 | 178 | 173 | 177 | 169 | 174 | 194 |
| Total Expenditure | 73 | 86 | 80 | 84 | 128 | 136 | 147 | 142 | 147 | 163 |
| Operating Profit | 16 | 18 | 17 | 28 | 51 | 36 | 30 | 27 | 26 | 31 |
| Interest | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 2 | 2 | 2 | 2 | 3 | 4 | 4 | 4 | 5 | 5 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 14 | 16 | 15 | 26 | 46 | 31 | 25 | 23 | 20 | 25 |
| Provision for Tax | 4 | 4 | 4 | 7 | 12 | 8 | 5 | 5 | 5 | 7 |
| Profit After Tax | 10 | 13 | 11 | 19 | 35 | 23 | 19 | 17 | 16 | 18 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Profit After Adjustments | 10 | 13 | 11 | 19 | 35 | 23 | 19 | 17 | 16 | 18 |
| Adjusted Earnings Per Share | 5.1 | 6.4 | 5.7 | 9.7 | 17.4 | 11.4 | 9.7 | 8.6 | 7.8 | 9 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 120 | 133 | 126 | 162 | 222 | 165 | 148 | 320 | 375 | 378 | 557 | 711 |
| Other Income | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 3 | 8 | 7 | 3 | 3 |
| Total Income | 120 | 134 | 127 | 162 | 223 | 166 | 149 | 324 | 383 | 385 | 560 | 714 |
| Total Expenditure | 112 | 125 | 112 | 141 | 169 | 138 | 115 | 244 | 299 | 306 | 426 | 599 |
| Operating Profit | 8 | 9 | 15 | 21 | 53 | 28 | 35 | 80 | 84 | 79 | 134 | 114 |
| Interest | 10 | 8 | 7 | 7 | 4 | 2 | 1 | 2 | 2 | 2 | 5 | 4 |
| Depreciation | 6 | 5 | 5 | 5 | 8 | 5 | 8 | 6 | 6 | 7 | 10 | 18 |
| Exceptional Income / Expenses | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -7 | 0 | 3 | 10 | 42 | 22 | 25 | 72 | 75 | 70 | 119 | 93 |
| Provision for Tax | -1 | -0 | 0 | 0 | 6 | 5 | 8 | 19 | 19 | 18 | 31 | 22 |
| Profit After Tax | -5 | 0 | 3 | 10 | 36 | 17 | 17 | 53 | 56 | 52 | 88 | 70 |
| Adjustments | 0 | 0 | -0 | -0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -5 | 0 | 3 | 9 | 36 | 17 | 18 | 54 | 56 | 52 | 88 | 70 |
| Adjusted Earnings Per Share | -2.7 | 0.2 | 1.7 | 4.9 | 18 | 8.5 | 8.8 | 26.7 | 28.1 | 26.3 | 44.2 | 35.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 47% | 20% | 28% | 17% |
| Operating Profit CAGR | 70% | 19% | 37% | 33% |
| PAT CAGR | 69% | 18% | 39% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 18% | 24% | 73% | 59% |
| ROE Average | 33% | 31% | 33% | 39% |
| ROCE Average | 42% | 42% | 46% | 37% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 5 | 5 | 3 | 13 | 48 | 65 | 83 | 134 | 184 | 230 | 312 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 6 | 7 | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1 | 1 | 1 | 1 | 6 | 5 | 4 | 4 | 4 | 5 | 7 |
| Total Current Liabilities | 90 | 86 | 68 | 68 | 48 | 19 | 44 | 56 | 83 | 84 | 138 |
| Total Liabilities | 95 | 92 | 78 | 88 | 107 | 89 | 131 | 193 | 272 | 319 | 457 |
| Fixed Assets | 53 | 49 | 45 | 41 | 34 | 33 | 40 | 40 | 55 | 61 | 168 |
| Other Non-Current Assets | 1 | 2 | 3 | 2 | 3 | 8 | 5 | 14 | 8 | 39 | 12 |
| Total Current Assets | 41 | 41 | 30 | 45 | 70 | 48 | 86 | 139 | 209 | 220 | 277 |
| Total Assets | 95 | 92 | 78 | 88 | 107 | 89 | 131 | 193 | 272 | 319 | 457 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 13 | 10 | 7 |
| Cash Flow from Operating Activities | 9 | 16 | 16 | 17 | 37 | 22 | 37 | 44 | 43 | 34 | 33 |
| Cash Flow from Investing Activities | -0 | -1 | -1 | -1 | -3 | -9 | -34 | -35 | -40 | -30 | -42 |
| Cash Flow from Financing Activities | -10 | -15 | -15 | -17 | -34 | -12 | -1 | -5 | -6 | -7 | 32 |
| Net Cash Inflow / Outflow | -0 | -0 | 0 | -0 | 0 | -0 | 2 | 5 | -3 | -3 | 23 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 7 | 10 | 7 | 30 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -2.65 | 0.2 | 1.65 | 4.85 | 18.03 | 8.51 | 8.76 | 26.71 | 28.14 | 26.31 | 44.18 |
| CEPS(Rs) | 0.17 | 2.59 | 4.02 | 7.33 | 22.05 | 10.83 | 13.01 | 29.52 | 31.31 | 29.82 | 49.43 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.5 | 3.25 | 3.5 | 4.5 |
| Book NAV/Share(Rs) | -0.17 | 0.03 | 1.63 | 6.33 | 24.07 | 32.68 | 41.72 | 67.01 | 92.37 | 115.51 | 156.38 |
| Core EBITDA Margin(%) | 6.03 | 5.97 | 10.44 | 12.69 | 23.7 | 16.26 | 22.5 | 23.79 | 20.3 | 19 | 23.53 |
| EBIT Margin(%) | 2.34 | 5.5 | 7.57 | 9.91 | 20.51 | 14.16 | 17.69 | 23.1 | 20.73 | 19.02 | 22.18 |
| Pre Tax Margin(%) | -5.01 | 0.26 | 2.37 | 5.92 | 18.78 | 13.12 | 16.94 | 22.47 | 20.13 | 18.53 | 21.32 |
| PAT Margin (%) | -4.01 | 0.27 | 2.37 | 5.85 | 16.22 | 10.3 | 11.82 | 16.64 | 14.97 | 13.88 | 15.83 |
| Cash Profit Margin (%) | 0.26 | 3.52 | 5.79 | 8.84 | 19.84 | 13.11 | 17.55 | 18.39 | 16.66 | 15.73 | 17.7 |
| ROA(%) | -5.24 | 0.43 | 3.88 | 11.65 | 36.76 | 17.27 | 15.86 | 32.85 | 24.15 | 17.77 | 22.72 |
| ROE(%) | -208.26 | 0 | 198.92 | 121.81 | 118.59 | 29.98 | 23.54 | 49.13 | 35.31 | 25.31 | 32.5 |
| ROCE(%) | 4.29 | 12.42 | 17.76 | 28.95 | 78.46 | 37.2 | 35.16 | 68.2 | 48.88 | 34.69 | 42.32 |
| Receivable days | 48.53 | 45.84 | 47.17 | 39.01 | 34.85 | 45.26 | 41.9 | 23.33 | 36.84 | 54.01 | 52.55 |
| Inventory Days | 63.33 | 48.55 | 37.82 | 30.62 | 38.85 | 52.35 | 51.45 | 37.81 | 46.03 | 53.88 | 48.78 |
| Payable days | 101.29 | 93.99 | 98.97 | 62.41 | 74.23 | 80.01 | 100.14 | 66.75 | 68.02 | 78.3 | 52.44 |
| PER(x) | 0 | 62.52 | 18.63 | 11.7 | 6.03 | 4.65 | 13.95 | 10.89 | 17.73 | 37.39 | 32.8 |
| Price/Book(x) | -42.43 | 451.21 | 18.85 | 8.96 | 4.52 | 1.21 | 2.93 | 4.34 | 5.4 | 8.52 | 9.27 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.55 | 0.65 | 0.36 | 0.31 |
| EV/Net Sales(x) | 0.7 | 0.65 | 0.91 | 0.97 | 1.03 | 0.48 | 1.6 | 1.77 | 2.62 | 5.17 | 5.2 |
| EV/Core EBITDA(x) | 10.14 | 9.44 | 7.54 | 7.34 | 4.26 | 2.84 | 6.85 | 7.13 | 11.69 | 24.74 | 21.6 |
| Net Sales Growth(%) | 2.33 | 11.18 | -5.2 | 28.08 | 36.96 | -25.67 | -10.26 | 116.49 | 17.11 | 0.85 | 47.29 |
| EBIT Growth(%) | -33.34 | 161.51 | 30.1 | 56.14 | 177.4 | -48.69 | 12.15 | 182.71 | 5.07 | -7.43 | 71.73 |
| PAT Growth(%) | -74.32 | 107.59 | 720.56 | 193.9 | 271.65 | -52.81 | 2.94 | 204.93 | 5.34 | -6.5 | 67.96 |
| EPS Growth(%) | -74.32 | 107.59 | 720.56 | 193.9 | 271.65 | -52.81 | 2.94 | 204.93 | 5.34 | -6.5 | 67.96 |
| Debt/Equity(x) | 13.81 | 11.08 | 16.56 | 3.44 | 0.25 | 0.01 | 0 | 0 | 0 | 0 | 0.13 |
| Current Ratio(x) | 0.46 | 0.48 | 0.45 | 0.66 | 1.47 | 2.58 | 1.97 | 2.49 | 2.51 | 2.62 | 2.01 |
| Quick Ratio(x) | 0.22 | 0.27 | 0.29 | 0.41 | 0.83 | 1.66 | 1.41 | 1.74 | 1.87 | 1.92 | 1.35 |
| Interest Cover(x) | 0.32 | 1.05 | 1.46 | 2.49 | 11.85 | 13.67 | 23.69 | 36.56 | 34.45 | 38.25 | 25.82 |
| Total Debt/Mcap(x) | 4.38 | 2.23 | 0.88 | 0.38 | 0.05 | 0.01 | 0 | 0 | 0 | 0 | 0.01 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 51.81 | 51.81 | 51.81 | 51.81 | 51.81 | 51.81 | 51.81 | 51.81 | 51.81 | 51.81 |
| FII | 0 | 0 | 0 | 0 | 0 | 0.15 | 0.08 | 0.12 | 0.1 | 0.03 |
| DII | 0.06 | 0.11 | 0.19 | 0.39 | 0.39 | 0.42 | 0.39 | 0.42 | 0.39 | 0.33 |
| Public | 48.13 | 48.08 | 48 | 47.8 | 47.8 | 47.62 | 47.72 | 47.65 | 47.7 | 47.83 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 | 1.03 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 |
| Public | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.95 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +47% | +20% | +28% | +17% |
| Operating Profit CAGR | +70% | +19% | +37% | +33% |
| PAT CAGR | +69% | +18% | +39% | — |
| Share Price CAGR | +18% | +24% | +73% | +59% |
| ROE Average | +33% | +31% | +33% | +39% |
| ROCE Average | +42% | +42% | +46% | +37% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 51.81 | 51.81 | 51.81 | 51.81 | 51.81 | 51.81 | 51.81 | 51.81 | 51.81 | 51.81 |
| FII | 0 | 0 | 0 | 0 | 0 | 0.15 | 0.08 | 0.12 | 0.1 | 0.03 |
| DII | 0.06 | 0.11 | 0.19 | 0.39 | 0.39 | 0.42 | 0.39 | 0.42 | 0.39 | 0.33 |
| Public | 48.19 | 48.19 | 48.19 | 48.19 | 48.19 | 48.19 | 48.19 | 48.19 | 48.19 | 48.19 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 | 1.03 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 |
| Public | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.96 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.